Research Study

Multiple Sclerosis: What's the relationship between your genes, your gut microbes and disease modifying drugs?
Principal Investigator 
Helen Tremlett

Overview

Body Locations and Systems 
Status 
Recruiting
Study Start/End 
Oct 1, 2016 to Dec 1, 2018
Locations 
UBC Hospital
Name/Title 
MS Bugs Study Research Assistant
Phone 
604-827-0765
Email Address 
ms.bugs@ubc.ca
Purpose of Study 

The purpose of the main study is to investigate adverse drug reactions from multiple sclerosis (MS) disease modifying drugs by understanding the genetic factors that contribute to their cause. 

The sub-study investigates how the MS disease modifying drugs affect microbes in the gut and how human DNA affects the changes in the gut microbes following drug treatment. We are also interested in how gut microbes might relate to progressive MS.

recruitment poster

Eligibility 

For both studies, all participants must have definite MS (i.e., have been told they have MS by a neurologist) and be at least 18 years of age. Further inclusion criteria may apply. 

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.